Select Medical(SEM)

Search documents
Select Medical(SEM) - 2021 Q2 - Quarterly Report
2021-08-05 20:36
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbers: 001-34465 SELECT MEDICAL HOLDINGS CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 20-1764048 (State or ...
Select Medical(SEM) - 2021 Q1 - Earnings Call Transcript
2021-05-08 00:35
Select Medical Holdings Corporation (NYSE:SEM) Q1 2021 Earnings Conference Call May 7, 2021 9:00 AM ET Company Participants Robert Ortenzio - Co-Founder & Executive Chairman Martin Jackson - Executive VP & CFO Conference Call Participants Justin Bowers - Deutsche Bank Frank Morgan - RBC Capital Markets Bill Sutherland - Benchmark Operator Good morning, and thank you for joining us today for the Select Medical Holdings Corporation earnings conference call to discuss the first quarter 2021 results and the com ...
Select Medical(SEM) - 2021 Q1 - Quarterly Report
2021-05-06 20:44
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file numbers: 001-34465 SELECT MEDICAL HOLDINGS CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 20-1764048 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification Number) 4714 Gettysburg Road, P.O. Box 2034 Mechanicsburg, PA 17055 (Address of Principa ...
Select Medical(SEM) - 2020 Q4 - Earnings Call Transcript
2021-02-26 19:14
Select Medical Holdings Corporation (NYSE:SEM) Q4 2020 Earnings Conference Call February 26, 2021 9:00 AM ET Company Participants Robert Ortenzio - Executive Chairman and Co-Founder Martin Jackson - Executive Vice President and Chief Financial Officer Conference Call Participants Justin Bowers - Deutsche Bank Frank Morgan - RBC Capital Markets Kevin Fischbeck - Bank of America Bill Sutherland - The Benchmark Company AJ Rice - Credit Suisse Operator Good morning and thank you for joining us today for Select ...
Select Medical(SEM) - 2020 Q4 - Annual Report
2021-02-25 21:36
Use these links to rapidly review the document TABLE OF CONTENTS INDEX TO FINANCIAL STATEMENTS Table of Contents 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbers: 001-34465 SELECT MEDICAL HOLDINGS C ...
Select Medical(SEM) - 2020 Q3 - Earnings Call Transcript
2020-10-30 18:30
Select Medical Holdings Corporation (NYSE:SEM) Q3 2020 Earnings Conference Call October 30, 2020 9:00 AM ET Company Participants Robert Ortenzio - Co-Founder and Executive Chairman Martin Jackson - EVP and CFO Conference Call Participants Frank Morgan - RBC Capital Markets Justin Bowers - Deutsche Bank Kevin Fischbeck - Bank of America Bill Sutherland - The Benchmark Company Rob Moonen - Credit Suisse Operator Good morning and thank you for joining us today for Select Medical Holdings Corporation's Earnings ...
Select Medical(SEM) - 2020 Q2 - Earnings Call Transcript
2020-07-31 18:08
Financial Data and Key Metrics Changes - The company's net revenue for Q2 2020 decreased by 9.4% to $1.23 billion compared to the same quarter last year [13] - Adjusted EBITDA for the second quarter was down 4% to $178.8 million, with an adjusted EBITDA margin of 14.5%, up from 13.7% in the same quarter last year [20][29] - Earnings per fully diluted share increased over 18% to $0.39 for the second quarter compared to $0.33 for the same quarter last year [26] Business Line Data and Key Metrics Changes - Critical illness recovery hospital segment net revenue increased by 12.7% to $520 million, with patient days up 5.3% and occupancy at 72% [14] - Rehabilitation hospital segment net revenue increased by 5.2% to $169 million, with a decline in patient days by 2.8% and occupancy at 71% [15] - Outpatient rehabilitation segment net revenue decreased by 36.2% to $167 million, with patient visits down 39.1% [16] - Concentra segment net revenue decreased by 24.5% to $312 million, with patient visits down 30.7% [18] Market Data and Key Metrics Changes - In June, outpatient rehabilitation volumes improved, with revenue down only 19.7% year-over-year compared to a 48% decline in April [11] - Concentra segment saw a decline of only 12.4% in June compared to prior year, showing recovery as restrictions eased [12] Company Strategy and Development Direction - The company continues to adapt and innovate in response to the COVID-19 pandemic, focusing on maintaining high-quality care while ensuring safety [6] - Management indicated that the pandemic has solidified the value of critical illness recovery hospitals and the continuum of care [102] - There are no significant M&A activities planned outside of acquiring remaining minority interests in Concentra, expected to occur in early 2022 [110] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the recovery of outpatient and Concentra segments, although they noted that outpatient rehab is more discretionary compared to Concentra [50] - The company anticipates strong cash flow for the remainder of the year, despite the repayment of Medicare advance payments starting in September [52] - Management highlighted the importance of relationships with referral sources, which have strengthened during the pandemic [96] Other Important Information - The company recorded $55 million in other operating income related to provider relief funds, with expectations of additional funds in the second half of the year [21][71] - Total available liquidity at the end of Q2 was over $1 billion, split between cash on hand and revolver availability [37] Q&A Session Summary Question: How is July trending across segments? - Management reported that July volumes are improving, with outpatient business down about 16% compared to June [40] Question: What is the mix driving strong pricing growth in critical illness recovery hospitals? - The increase in acuity of patients has contributed to the strong pricing growth, with a case mix index of 1.3 this quarter [42] Question: What are the main uncertainties holding back guidance for the second half? - The uncertainties mainly revolve around the outpatient side and the impact of COVID flare-ups [62] Question: How is the company managing labor force and telehealth utilization? - Telehealth visits increased significantly during the pandemic, but are now decreasing as in-person visits resume [55] Question: What is the company's outlook on M&A opportunities? - The company is focusing on internal development opportunities rather than significant acquisitions in the near term [110]
Select Medical(SEM) - 2020 Q1 - Earnings Call Transcript
2020-05-01 18:36
Select Medical Holdings Corporation (NYSE:SEM) Q1 2020 Earnings Conference Call May 1, 2020 9:00 AM ET Company Participants Robert Ortenzio - Co-Founder & Executive Chairman Martin Jackson - Executive Vice President & Chief Financial Officer Conference Call Participants Frank Morgan - RBC Capital Markets Justin Bowers - Deutsche Bank Peter Costa - Wells Fargo A.J. Rice - Credit Suisse Kevin Fischbeck - Bank of America David Common - JPMorgan Bill Sutherland - Benchmark Operator Good morning and thank you fo ...
Select Medical(SEM) - 2019 Q4 - Earnings Call Transcript
2020-02-21 20:30
Select Medical Holdings Corp (NYSE:SEM) Q4 2019 Earnings Conference Call February 21, 2020 9:00 AM ET Company Participants Robert Ortenzio - Co-Founder and Executive Chairman Martin Jackson - Executive Vice President and Chief Financial Officer Conference Call Participants Frank Morgan - RBC Capital Markets Justin Bowers - Deutsche Bank A.J. Rice - Credit Suisse Kevin Fischbeck - Bank of America Bill Sutherland - Benchmark Operator Good morning, and thank you for joining us today for Select Medical Holdings ...
Select Medical(SEM) - 2019 Q3 - Earnings Call Transcript
2019-11-01 17:06
Select Medical Holdings Corp (NYSE:SEM) Q3 2019 Earnings Conference Call November 1, 2019 9:00 AM ET Company Participants Robert Ortenzio - Co-Founder & Executive Chairman Martin Jackson - EVP & CFO Conference Call Participants Frank Morgan - RBC Capital Markets Peter Costa - Wells Fargo Securities Joanna Gajuk - Bank of America Merrill Lynch, Research Division Justin Bowers - Deutsche Bank A.J. Rice - Crédit Suisse Operator Good morning, and thank you for joining us today for Select Medical Holdings Corpor ...